Climate change, energy crisis, the call for a more environmentally compatible production method and socially responsible action do not stop at the pharmaceutical and...
The Fill & Finish of biologic drugs is expensive and poses special technological challenges for CDMOs. At the German site in Hameln, Siegfried has successfully proven...
Science and technology group 3M has announced plans to invest $146 million to expand its biopharma filtration capabilities at manufacturing facilities in Europe. The...
Italian API producer Olon has started building a second facility at its Rodano site in Milan that will be entirely dedicated to producing ultra-potent compounds.
Germany’s Merck is investing €35 million in biosafety testing at its Glasgow and Stirling sites in Scotland. When completed – no date has been given – the company said...
PPG has announced plans to spend $44 million on upgrading five of its powder coatings plants in the US, Mexico and Brazil, to meet growing customer demand for more...
Swiss CDMO Lonza has acquired Dutch-based Synaffix, a biotech focused on ADC development. The deal comprises an initial cash injection of €100 million and up to €60...
The CDMO (contract development and manufacturing organizations) business has a bright future, of that Siegfried CEO Wolfgang Wienand is certain. The economic advantages...
Evonik has inked a new non-exclusive deal with compatriot ProductionToGo, covering distribution of the German specialty chemicals group’s 3D printing materials.
